You are here: Industry Insights > mTNBC

News List

Alphamab Oncology Presented Clinical Data of KN046 Combined with Nab-paclitaxel in the Treatment of mTNBC at AACR 2021 prnasia
April 13, 2021
Alphamab Oncology announced that data from phase Ib/II clinical study (clinical trial No.: KN046-203) of PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel for the treatment of patients with metastatic triple-negative breast ...
First Patient Dosed in Trodelvy Trial for Metastatic Triple-Negative Breast Cancer americanpharmaceuticalreview
November 12, 2020
Everest Medicines announced the first patient has been dosed in China into the EVER-132-001 Phase 2b registration clinical trial evaluating Trodelvy (sacituzumab govitecan, IMMU-132) for the treatment of patients with metastatic triple-negative ...
FDA Announces Efficacy, Safety Concerns with Breast Cancer Treatment americanpharmaceuticalreview
September 14, 2020
The U.S. Food and Drug Administration (FDA) is alerting health care professionals, oncology clinical investigators, and patients that a clinical trial studying the use of atezolizumab (Tecentriq) and paclitaxel in patients with previously untreated ...